tiprankstipranks
Seres Therapeutics (MCRB)
NASDAQ:MCRB
Holding MCRB?
Track your performance easily

Seres Therapeutics (MCRB) Financial Statements

1,015 Followers

Seres Therapeutics Financial Overview

Seres Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.19; its P/E ratio is -0.58; Seres Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ 64.00K$ 310.00K
Gross Profit---$ 64.00K$ 310.00K
EBIT$ -51.03M$ -29.42M$ -33.05M-$ -43.84M
EBITDA$ -49.17M$ -27.52M$ -31.03M-$ -42.16M
Net Income Common Stockholders$ 88.78M$ -35.46M$ -37.72M$ -41.25M$ -47.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 66.82M$ 71.23M$ 111.18M$ 127.97M$ 169.91M
Total Assets$ 178.74M$ 321.73M$ 341.26M$ 358.60M$ 367.70M
Total Debt$ 93.61M$ 212.63M$ 214.18M$ 213.94M$ 212.28M
Net Debt$ 26.79M$ 141.39M$ 103.00M$ 85.97M$ 42.37M
Total Liabilities$ 154.82M$ 408.81M$ 401.00M$ 403.46M$ 382.82M
Stockholders Equity$ 23.92M$ -87.07M$ -59.74M$ -44.86M$ -15.12M
Cash Flow-
Free Cash Flow$ -34.81M$ -39.91M$ -35.30M-$ -61.05M
Operating Cash Flow$ -34.68M$ -39.81M$ -35.24M$ -47.50M$ -59.26M
Investing Cash Flow$ 141.14M$ 1.30M$ -62.00K$ -877.00K$ -1.80M
Financing Cash Flow$ -110.87M-$ 18.76M$ 6.43M$ 1.44M
Currency in USD

Seres Therapeutics Earnings and Revenue History

Seres Therapeutics Debt to Assets

Seres Therapeutics Cash Flow

Seres Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis